Drug comparisons
Fremanezumab vs Atogepant
Compare Fremanezumab (Ajovy) injectable CGRP mAb vs Atogepant (Qulipta) oral gepant for migraine prevention. Differences in route, dosing, and side effects.
No comparison dimensions are available for this page.
Clinical context
This comparison typically arises for patients choosing between injectable CGRP antibodies and oral gepants for migraine prophylaxis.
Bottom line
Both Fremanezumab and Atogepant are effective CGRP therapies for migraine prevention with the choice driven by administration preference.
All medication comparisons